Akshat Kshetrapal
Investment Director @ DSM Venturing
Amsterdam, The Netherlands
Akshat Kshetrapal is a seed investor at DSM Venturing in Amsterdam focused on Health Care and Biopharma. Akshat Kshetrapal is the Investment Director at DSM Venturing.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Akshat Kshetrapal invests in
Stages Akshat Kshetrapal invests in
Countries Akshat Kshetrapal invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Biopharma 1 (33%)
- Organic Food 1 (33%)
- Biotechnology 1 (33%)
- Bioinformatics 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Series C 1 (33%)
Country
- Denmark 1 (33%)
- The Netherlands 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Octarine Bio
|
Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $5.9M / Series A / Jan 22, 2026 | |
NutriLeads
|
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiatescientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers. | $4.9M / Series C / Dec 18, 2023 | |
|
Octarine Bio
|
Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $2M / Seed / Sep 20, 2022 |
Co-Investors
About DSM Venturing
Founded in 2002, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.
DSM Venturing Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Akshat Kshetrapal
Investment Director
|
|||
Arpesh Mehta
Investment Director
|
|||
Greg McParland
Investment Director
|
|||
Iulian Baxan
Analyst
|
|||
Luda Kopeikina
Investment Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Akshat Kshetrapal invest in?
Akshat Kshetrapal invests primarily in Health Care, Biopharma and Organic Food startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Akshat Kshetrapal last invest?
The most recent investment recorded for Akshat Kshetrapal closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
